Glialia oral suspension is a food supplement containing palmitoylethanolamide (PEA) and luteolin in a 10:1 ratio (particle size between 0.8 and 6.0 microns), and acts in the body by promoting the control of the physiological reactivity of the central nervous tissue. It is indicated for subjects with disorders characterized by microglial and astroglial-induced neuroinflammation and therefore at risk of triggering neurodegeneration processes.
Composition
Palmitoylethanolamide + luteolin in co-ultramicronized form (ultramicrocomposite Pealut) 700 mg + 70 mg in 10 ml.
Gluten-free.
Directions for use
Must be used under medical supervision.
Take 10 ml 1-2 times a day for 20-30 day cycles, repeated if necessary.
The product is particularly suitable for subjects with swallowing difficulties.
The suspension is ready to be administered via SNG or PEG*.
*SNG-Tube Nasogastric; PEG-Percutaneous Endoscopic Gastrostomy
Warnings
Use under medical supervision.
Keep out of reach of children under 3 years of age.
Use of this product during pregnancy is not recommended.
Storage
Store at room temperature.
Shelf life from the date of manufacture, in unopened packaging: 36 months.
Product images are purely indicative and may differ in graphics, size or content . Even the names of the products, the ingredients and the percentages described are purely indicative and the manufacturing companies could make changes or updates. The only element of identification is the ministerial code MINSAN. Pharmaserena declines all responsibility for any errors, omissions or lack of product updates.